Brixmor Property Group (BRX)
NYSEReal EstateReit - RetailSnapshot 2026-10-29
$29.16+2.68%
Close 2026-10-29 · 1-day change
NYSEReal EstateReit - RetailSnapshot 2026-10-29
Research Workspace
Put BRX beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Retail REITs is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — EPS growth to at least $1.18 in 2026: Direct metric needs a verified mapping.
View ThesisRevenue is growing steadily — about 6% over the past year.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 19%, softest on free-cash-flow margins.
View QualityManagement screens strong on capital allocation, earnings delivery, the balance sheet.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationRelatively steady — typically moves about 1% a day.
View RiskBRX’s thesis centers on acquisitions and reinvestment supporting same-property growth and cash distributions. Revenue grew 4.9% year over year in Q2 FY2026, down from 5.6% in Q1. Q1 earnings beat, while Q3 GAAP EPS was $0.28 with no recorded surprise verdict. BRX trades at 10.3× P/FFO versus the 11.1× peer median; expectations look modest versus our view. Our model puts the next-quarter miss probability near 25%. The EPS-growth pillar needs verified metric mapping, so the peer discount still requires execution. Peer multiples imply a price about 13% above where it trades; the thesis is on watch. This read is provisional.
Trailing returns as of 2026-10-29. BRX is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 15 analysts currently covering BRX (as of Oct 2026).
Based on 6 Wall Street analysts offering 12-month price targets for BRX in the last 4 months.
Continue this research
Compare BRX with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| BRX Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 7 valuation methods, at three horizons. As of 2026-10-29. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Retail REITs — fair value, gap to price, and forward P/E.
Compare the value case
Put BRX next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Maintain and grow the dividend per share
A 7.3% dividend increase directly advances dividend growth and signals confidence in cash flows.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-29. EPS is implied from price ÷ P/E. Not investment advice.
Current $29.16
The last 12 months of price, then the range of analyst 12-month targets from today’s $29.16.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Increase same property NOI growth
Raised same-property NOI outlook supports growth, while 2026 FFO guidance provides earnings visibility.
Advances: Expand portfolio via strategic acquisitions and partnerships
Acquisition aligns with strategic growth objectives.
Advances: Execute value-enhancing reinvestment projects
Acquisition supports value-enhancing reinvestment projects.
Advances: Increase same property NOI growth
Increased same-property NOI growth aligns with growth objectives.
Advances: Increase revenue growth
Acquisition enhances revenue growth potential significantly.